Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4GL7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,455
Award facts
- Contract value 100% obligated
- $10,455.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,455.09 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 20, 2026, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside award with a completion date of January 21, 2026, and performance at the contractor's location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication primarily indicated for chronic weight management in adults with obesity or overweight conditions, reflecting the federal government's investment in pharmaceutical treatments for metabolic health conditions within military and defense healthcare systems.
This delivery order operates under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally. As a major pharmaceutical distributor, Amerisourcebergen has demonstrated capability to fulfill federal medical procurement requirements through competitive procurement processes, providing diverse medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4GL7?
SPE2DR26F4GL7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F4GL7 worth?
The government has obligated $10,455 on SPE2DR26F4GL7.
Is contract SPE2DR26F4GL7 an order under another contract?
Yes. SPE2DR26F4GL7 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GL7 competed?
The extent of competition for SPE2DR26F4GL7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award